发明名称 FACTOR VIII: REMODELING AND GLYCOCONJUGATION OF FACTOR VIII
摘要 The invention includes methods and compositions for remodeling a peptide molecule, including the addition or deletion of one or more glycosyl groups to a peptide, and/or the addition of a modifying group to a peptide.
申请公布号 US2016200795(A1) 申请公布日期 2016.07.14
申请号 US201514974841 申请日期 2015.12.18
申请人 Novo Nordisk A/S 发明人 DeFrees Shawn;Zopf David A.;Bayer Robert J.;Bowe Caryn;Hakes David James;Chen Xi
分类号 C07K14/755;A61K47/48;A61K38/37;C07K1/107 主分类号 C07K14/755
代理机构 代理人
主权项 1. A covalent conjugate comprising Factor VIII and a linear or a branched poly(ethylene glycol), wherein the a linear or a branched poly(ethylene glycol) is conjugated directly onto the peptide backbone of Factor VIII or conjugated onto the peptide backbone of Factor VIII via a linker, wherein the in vivo half-life of the conjugate is increased by at least about 40% compared to the in vivo half-life of a wild-type Factor VIII, wherein the linear or branched poly(ethylene glycol) has a degree of polymerization of from about 1 to about 5,000.
地址 Bagsvaerd DK